Aliskiren/amlodipine/hydrochlorothiazide
| Combination of | |
|---|---|
| Aliskiren | Renin inhibitor |
| Amlodipine | Calcium channel blocker |
| Hydrochlorothiazide | Diuretic |
| Clinical data | |
| AHFS/Drugs.com | Consumer Drug Information |
| Licence data | |
| Pregnancy category |
|
| Routes of administration | Oral |
| Legal status |
|
| Identifiers | |
| CAS Number | 1486517-17-2 |
| ATC code | C09XA54 |
| (verify) | |
The drug combination aliskiren/amlodipine/hydrochlorothiazide (INNs, trade name Amturnide) is an antihypertensive approved by the U.S. Food and Drug Administration (FDA) on December 21, 2010.[1]
References
External links
| ||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Monday, February 15, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.